Cyclins D1, D3, E, and A in vulvar carcinoma patients

Gynecologic Oncology

Volumn 97, Issue 3, 2005, Pages 733-739

  Knopp, Synne ^a   Bjørge, Tone ^a   Nesland, Jahn M ^a   Tropé, Claes ^a   Holm, Ruth ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cell cycle; Cyclin A; Cyclin D1; Cyclin D3; Cyclin E; Immunohistochemistry; Squamous cell carcinoma

Indexed keywords

BIOTIN; CYCLIN A; CYCLIN D1; CYCLIN D3; CYCLIN E; MOLECULAR MARKER; PEROXIDASE; STREPTAVIDIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR VOLUME; VULVA CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 20444440618     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.03.025     Document Type: Article

References (59)

1. J. Coulter, and N. Gleeson Local and regional recurrence of vulval cancer: management dilemmas Best Pract. Res. Clin. Obstet. Gynaecol. 17 2003 663 681
2. R.W. Jones, J. Baranyai, and S. Stables Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia Obstet. Gynecol. 90 1997 448 452
3. M.J. Messing, and D.G. Gallup Carcinoma of the vulva in young women Obstet. Gynecol. 86 1995 51 54
4. S.K. Tyring Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment Am. J. Obstet. Gynecol. 189 2003 S17 S23
5. J.L. Benedet, H. Bender, H. Jones III, H.Y. Ngan, and S. Pecorelli FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int. J. Gynaecol. Obstet. 70 2000 209 262
6. M.K. Fehr, R. Hornung, and V.A. Schwarz Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid Gynecol. Oncol. 80 2001 62 66
7. D.H. Moore, G.M. Thomas, and G.S. Montana Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group Int. J. Radiat. Oncol., Biol., Phys. 42 1998 79 85
8. N U.S. National Cancer Institute. Vulvar cancer (PDQ) treatment. 2004; http://cancer.gov/cancertopics/pdq/treatment/vulvar/healthprofessional.
9. J.A. de Hullu, H. Hollema, and S. Lolkema Vulvar carcinoma. The price of less radical surgery Cancer 95 2002 2331 2338
10. S.H. Zhang, A.K. Sood, J.I. Sorosky, B. Anderson, and R.E. Buller Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva Cancer 89 2000 1520 1525
11. M. Scheistroen, J.M. Nesland, and C. Trope Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991 Eur. J. Gynaecol. Oncol. 23 2002 93 103
12. I.B. Weinstein Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis Carcinogenesis 21 2000 857 864
13. C.J. Sherr Mammalian G1 cyclins Cell 73 1993 1059 1065
14. J. Lukas, T. Herzinger, and K. Hansen Cyclin E-induced S phase without activation of the pRb/E2F pathway Genes Dev. 11 1997 1479 1492
15. P. Nurse Ordering S phase and M phase in the cell cycle Cell 79 1994 547 550
16. T. Kamai, K. Takagi, and H. Asami Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer Br. J. Cancer 84 2001 1242 1251
17. J. Richter, U. Wagner, and J. Kononen High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer Am. J. Pathol. 157 2000 787 794
18. I.R. Bukholm, G. Bukholm, and J.M. Nesland Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas Int. J. Cancer 93 2001 283 287
19. V.A. Florenes, R.S. Faye, G.M. Maelandsmo, J.M. Nesland, and R. Holm Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma Clin. Cancer Res. 6 2000 3614 3620
20. M. Filipits, U. Jaeger, and G. Pohl Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma Clin. Cancer Res. 8 2002 729 733
21. D.S. Bae, S.B. Cho, and Y.J. Kim Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus Gynecol. Oncol. 81 2001 341 347
22. T.H. Cheung, M.M. Yu, and K.W. Lo Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix Cancer Lett. 166 2001 199 206
23. S. Aaltomaa, P. Lipponen, and M. Ala-Opas Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival Br. J. Cancer 80 1999 2001 2007
24. K.J. Rolfe, J.C. Crow, and E. Benjamin Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions Int. J. Gynecol. Cancer 11 2001 381 386
25. E. Lerma, M. Esteller, J.G. Herman, and J. Prat Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus Hum. Pathol. 33 2002 1120 1125
26. J.H. Shepherd Cervical and vulvar cancer: changes in FIGO definitions of staging Br. J. Obstet. Gynecol. 103 1996 405 406
27. P. Kleihues, and L.H. Sobin Pathology and genetics of tumors of the breast and female genital organs F.A. Tavassoli J.A. Diehl World Health Organization of Tumours 2003 IARC Press 316 321
28. S. Knopp, T. Bjorge, and J.M. Nesland p16INK4a and p21WAF1/CIP1 expression correlates with clinical outcome in vulvar carcinomas Gynecol. Oncol. 95 2004 37 45
29. M. Scheistroen, C. Trope, E.O. Pettersen, and J.M. Nesland p53 protein expression in squamous cell carcinoma of the vulva Cancer 85 1999 1133 1138
30. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J. Am. Assoc. 53 1958 457 481
31. N.H. Cho, Y.T. Kim, and J.W. Kim Correlation between G1 cyclins and HPV in the uterine cervix Int. J. Gynecol. Pathol. 16 1997 339 347
32. H. Skomedal, G.B. Kristensen, A.K. Lie, and R. Holm Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas Gynecol. Oncol. 73 1999 223 228
33. Y. Koyamatsu, M. Yokoyama, and Y. Nakao A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas Gynecol. Oncol. 90 2003 547 551
34. A.K. Lie, S. Skarsvag, H. Skomedal, O.A. Haugen, and R. Holm Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection Int. J. Gynecol. Pathol. 18 1999 5 11
35. D.E. Engelman, L.A. Andrade, and J. Vassallo Human papillomavirus infection and p53 protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma Braz. J. Med. Biol. Res. 36 2003 1159 1165
36. U. Hording, B. Kringsholm, and B. Andreasson Human papillomavirus in vulvar squamous-cell carcinoma and in normal vulvar tissues: a search for a possible impact of HPV on vulvar cancer prognosis Int. J. Cancer 55 1993 394 396
37. D. Rusk, G.P. Sutton, K.Y. Look, and A. Roman Analysis of invasive squamous cell carcinoma of the vulva and vulvar intraepithelial neoplasia for the presence of human papillomavirus DNA Obstet. Gynecol. 77 1991 918 922
38. C.L. Trimble, A. Hildesheim, L.A. Brinton, K.V. Shah, and R.J. Kurman Heterogeneous etiology of squamous carcinoma of the vulva Obstet. Gynecol. 87 1996 59 64
39. Y.Y. Lee, S.P. Wilczynski, A. Chumakov, D. Chih, and H.P. Koeffler Carcinoma of the vulva: HPV and p53 mutations Oncogene 9 1994 1655 1659
40. H. Muller, J. Lukas, and A. Schneider Cyclin D1 expression is regulated by the retinoblastoma protein Proc. Natl. Acad. Sci. U. S. A. 91 1994 2945 2949
41. K. Zerfass, A. Schulze, and D. Spitkovsky Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation J. Virol. 69 1995 6389 6399
42. H. Dosaka-Akita, F. Hommura, and T. Mishina A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis Cancer Res. 61 2001 2500 2504
43. E. Rosenberg, R.I. Demopoulos, and A. Zeleniuch-Jacquotte Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival Hum. Pathol. 32 2001 808 813
44. G. van de Putte, G.B. Kristensen, A.K. Lie, M. Baekelandt, and R. Holm Cyclins and proliferation markers in early squamous cervical carcinoma Gynecol. Oncol. 92 2004 40 46
45. T. Oshita, K. Shigemasa, N. Nagai, and K. Ohama p27, cyclin E, and CDK2 expression in normal and cancerous endometrium Int. J. Oncol. 21 2002 737 743
46. A. Dellas, E. Schultheiss, M.R. Leivas, H. Moch, and J. Torhorst Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms Anticancer Res. 18 1998 3991 3998
47. K.Y. Tae, C.E. Kyoung, and C.N. Hoon Expression of cyclin E and p27(KIP1) in cervical carcinoma Cancer Lett. 153 2000 41 50
48. A.J. Ferreri, M. Ponzoni, and G. Pruneri Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma Int. J. Cancer 94 2001 599 604
49. R. Chetty, and C.W. Sitti Cyclin E immunoexpression in gastric cancer does not correlate with clinicopathological parameters Histopathology 42 2003 66 69
50. H.M. Chen, K.M. Yen-Ping, K.H. Lin, C.Y. Lin, and C.P. Chiang Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan Oral. Oncol. 39 2003 476 482
51. Y. Dong, L. Sui, Y. Watanabe, K. Sugimoto, and M. Tokuda Aberrant expression of cyclin A in laryngeal squamous cell carcinoma Anticancer Res. 22 2002 83 89
52. M. Furihata, T. Ishikawa, and A. Inoue Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma Clin. Cancer Res. 2 1996 1781 1785
53. H.C. Shih, T. Shiozawa, and K. Kato Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator Hum. Pathol. 34 2003 471 478
54. V.A. Florenes, G.M. Maelandsmo, R. Faye, J.M. Nesland, and R. Holm Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome J. Pathol. 195 2001 530 536
55. N. Kyushima, J. Watanabe, and H. Hata Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables J. Cancer Res. Clin. Oncol. 128 2002 307 312
56. M. Cheng, P. Olivier, and J.A. Diehl The p21/Cip1 and p27/Kip1 "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts EMBO J. 18 1999 1571 1583
57. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
58. W.G. Nelson, and M.B. Kastan DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways Mol. Cell. Biol. 14 1994 1815 1823
59. S. el Deiry, J.W. Harper, and P.M. O'Connor WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res. 54 1994 1169 1174